BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 29, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 15, 2005
View Archived Issues
Amgen Offers To Buy Out Abgenix For $2.2B In Cash
In what could become one of the top acquisitions of 2005, Amgen Inc. offered to acquire Abgenix Inc. for $22.50 a share - or about $2.2 billion in cash. (BioWorld Today)
Read More
Zadaxin Phase III Miss Drops SciClone's Stock 40 Percent
Read More
Arena's Obesity Drug Yields Positive Results In Phase IIb
Read More
Optimer Brings In $34.2M To Advance Anti-Infectives
Read More
ActivBiotics, Metaphore Merge With Two Late-Stage Therapies
Read More
Human Genome Sciences Spinning Out CoGenesys
Read More
Other News To Note
Read More
